相似文献
1
Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?
World J Gastroenterol. 2006 Mar 28;12(12):1829-41. doi: 10.3748/wjg.v12.i12.1829.
2
The role of genetics in inflammatory bowel disease.
Curr Drug Targets. 2008 May;9(5):361-8. doi: 10.2174/138945008784221161.
3
Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.
Inflamm Bowel Dis. 2006 May;12(5):355-61. doi: 10.1097/01.MIB.0000217338.23065.58.
4
Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases.
World J Gastroenterol. 2007 Feb 28;13(8):1221-9. doi: 10.3748/wjg.v13.i8.1221.
5
Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
World J Gastroenterol. 2005 Feb 7;11(5):681-5. doi: 10.3748/wjg.v11.i5.681.
6
Advances in the molecular dissection of inflammatory bowel disease.
Semin Immunol. 2006 Aug;18(4):244-53. doi: 10.1016/j.smim.2006.03.012. Epub 2006 May 5.
7
Pediatric inflammatory bowel disease: clinical and molecular genetics.
Inflamm Bowel Dis. 2007 Nov;13(11):1430-8. doi: 10.1002/ibd.20213.
8
Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Clin Exp Immunol. 2016 Mar;183(3):358-68. doi: 10.1111/cei.12732. Epub 2015 Nov 26.
9
NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
Eur Cytokine Netw. 2006 Jun;17(2):125-30.
10
NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.
Dig Dis Sci. 2013 Sep;58(9):2599-607. doi: 10.1007/s10620-013-2696-8. Epub 2013 May 26.
引用本文的文献
1
Experimental allergic airway inflammation impacts gut homeostasis in mice.
Heliyon. 2023 Jun 3;9(6):e16429. doi: 10.1016/j.heliyon.2023.e16429. eCollection 2023 Jun.
2
Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.
Saudi J Gastroenterol. 2023 Jul-Aug;29(4):233-239. doi: 10.4103/sjg.sjg_468_22.
3
PROBIOTIC APPROACHES FOR TARGETING INFLAMMATORY BOWEL DISEASE: AN UPDATE ON ADVANCES AND OPPORTUNITIES IN MANAGING THE DISEASE.
Int J Probiotics Prebiotics. 2016;11(3-4):99-116.
4
Lack of Association between Interleukin 23R (IL-23R) rs10889677 Polymorphism and Inflammatory Bowel Disease Susceptibility In an Iranian Population.
Rep Biochem Mol Biol. 2018 Oct;7(1):16-22.
5
Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).
Drugs Context. 2018 Mar 6;7:212505. doi: 10.7573/dic.212505. eCollection 2018.
6
Gastrocnemius Myalgia as a Rare Initial Manifestation of Crohn's Disease.
Intern Med. 2018 Jul 15;57(14):2001-2006. doi: 10.2169/internalmedicine.0327-17. Epub 2018 Feb 28.
7
Impact of Novel Sorghum Bran Diets on DSS-Induced Colitis.
Nutrients. 2017 Mar 27;9(4):330. doi: 10.3390/nu9040330.
8
Clinical and Sociodemographic Aspects of Inflammatory Bowel Disease Patients.
Gastroenterology Res. 2015 Aug;8(3-4):207-215. doi: 10.14740/gr649w. Epub 2015 Jul 22.
9
Adrenal-Derived Hormones Differentially Modulate Intestinal Immunity in Experimental Colitis.
Mediators Inflamm. 2016;2016:4936370. doi: 10.1155/2016/4936370. Epub 2016 Jun 14.
10
Bactericidal permeability increasing protein gene polymorphism is associated with inflammatory bowel diseases in the Turkish population.
Saudi J Gastroenterol. 2015 Jul-Aug;21(4):239-44. doi: 10.4103/1319-3767.161642.
本文引用的文献
1
Enteric Microflora in IBD: Pathogens or Commensals?
Inflamm Bowel Dis. 1997 Fall;3(3):230-5.
2
Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery.
Hepatogastroenterology. 2005 May-Jun;52(63):817-22.
3
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
Gut. 2005 Oct;54(10):1421-7. doi: 10.1136/gut.2005.066340. Epub 2005 Jun 14.
4
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Gastroenterology. 2005 Jun;128(7):2020-8. doi: 10.1053/j.gastro.2005.03.046.
5
Probiotics in inflammatory bowel disease: possible mechanisms of action.
Curr Opin Gastroenterol. 2005 Jul;21(4):426-30.
6
Recent advances in the genetics of inflammatory bowel disease.
Curr Opin Gastroenterol. 2005 Jul;21(4):401-7.
7
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
Gut. 2005 Nov;54(11):1553-7. doi: 10.1136/gut.2005.065888. Epub 2005 May 31.
8
Association between Toll-like receptor 4 and inflammatory bowel disease.
Inflamm Bowel Dis. 2005 Jun;11(6):567-75. doi: 10.1097/01.mib.0000161305.81198.0f.
9
DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.
Gut. 2005 Oct;54(10):1416-20. doi: 10.1136/gut.2005.066621. Epub 2005 Apr 20.
10
Association of DLG5 R30Q variant with inflammatory bowel disease.
Eur J Hum Genet. 2005 Jul;13(7):835-9. doi: 10.1038/sj.ejhg.5201403.
Zotero 插件